Bone health in cancer: ESMO Clinical Practice Guidelines
2020 · Annals of Oncology · 492 citations
https://doi.org/10.1016/j.annonc.2020.07.019
J
Jean‐Jacques Body
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
358
Papers
12.7K
Citations
60
h-index
173
i10-index
Jean‐Jacques Body is an academic researcher from Université Libre de Bruxelles. The author has contributed to research in topics: Bone health and treatments & Radiopharmaceutical Chemistry and Applications & Bone health and osteoporosis research. The author has an h-index of 60, co-authored 305 publications.
ORCID: 0000-0002-9165-1444Papers by this author
worksFracture Risk and Management of Discontinuation of Denosumab Therapy: A Systematic Review and Position Statement by ECTS
2020 · The Journal of Clinical Endocrinology & Metabolism · 336 citations
https://doi.org/10.1210/clinem/dgaa756
Fracture risk reduction and safety by osteoporosis treatment compared with placebo or active comparator in postmenopausal women: systematic review, network meta-analysis, and meta-regression analysis of randomised clinical trials
2023 · BMJ · 180 citations
https://doi.org/10.1136/bmj-2021-068033
Increased Dickkopf-1 expression in breast cancer bone metastases
2007 · British Journal of Cancer · 175 citations
https://doi.org/10.1038/sj.bjc.6603959
Non-pharmacological management of osteoporosis: a consensus of the Belgian Bone Club
2011 · Osteoporosis International · 135 citations
https://doi.org/10.1007/s00198-011-1545-x
The Src inhibitor dasatinib accelerates the differentiation of human bone marrow-derived mesenchymal stromal cells into osteoblasts
2010 · BMC Cancer · 78 citations
https://doi.org/10.1186/1471-2407-10-298
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat